Search Tag: Charles M. Baum
2022 18 May
Poseida Therapeutics, Inc. a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure announced the appointment of Charles M. Baum , M.D., Ph.D., to its Board of Directors, effective May 16, 2022 . Additionally, the Company announced the...Read more